The Pulse
Providers seek AI oversight as authorization delays fall in survey
A Cohere Health survey found fewer clinicians reported patients abandoning treatment because of prior authorization delays than a year earlier. Most respondents said they trusted AI in the process, while seeking transparency and human oversight.

The share of clinicians reporting that patients abandoned recommended treatment because of prior authorization delays fell from 55% to 28% year over year, according to a Cohere Health survey. In results released on Nov. 16, the company also said 96% of clinicians and 94% of office administrators continued to trust AI in prior authorization, while seeking more transparency and human oversight.
Prior authorization is the process health plans use to review certain treatments before they are delivered. Cohere conducted the second annual survey with Wakefield Research, reaching 100 clinicians and 100 office administrators at U.S. hospitals and medical systems.
Reports of delayed care
The company said respondents reported fewer avoidable emergency-room visits or hospital care associated with authorization delays. It also found that providers saw the most value in AI handling routine administrative work and helping requests move faster.
Providers still face unclear documentation requirements and inconsistent processes across health plans, according to Cohere. The company said those problems can lead to avoidable denials when providers do not know what information is needed and when.
Cohere sells a clinical intelligence and operations platform and AI-powered services for health plans. Its chief medical officer, Dr. Brian Covino, said providers want AI to reduce manual work and speed care while keeping clinical judgment and human oversight in control.
He said AI should “never be used to deny care” and should instead help streamline administrative work. Cohere's survey findings were published alongside a white paper on providers' views of AI and prior authorization.
Trust with conditions
Cohere said providers wanted greater transparency, consistency and oversight, even as most respondents continued to express trust in AI for prior authorization. It characterized that trust as increasingly conditional and said respondents wanted clearer rules and better guidance as well as less administrative work.
The company's earlier survey, released in October 2025, also included 200 U.S. clinicians and office administrators. In that survey, 99% of clinicians and 96% of administrators reported confidence in AI-driven prior authorization, according to Cohere.
Earlier findings on paperwork
The earlier survey found that 16% of office administrators and 24% of clinicians used electronic prior authorization platforms for more than 40% of their submissions. Cohere also reported that about a quarter of requests were submitted by fax or phone.
In the 2025 survey, 92% of clinicians and 89% of administrators said they were frequently unsure whether a treatment required authorization. Two-thirds of respondents said a fully digital process would significantly improve their workflows, while nearly all agreed it should include real-time tracking of requests, according to the company.
Sources
- Original source · Press release Cohere Health · National survey shows progress on prior authorization delay… prnewswire.com
Other pages read
Related stories
- AMA and state medical boards say AI oversight and liability frameworks need modernizing
- Medical AI startup Alterra Labs raises $12.5 million in seed funding
- EliseAI Raises $350M at a $4B Valuation
- OpenEvidence Raises $250 Million at a $15 Billion Valuation
- Stony Brook study finds clinicians favor AI discharge summaries 95%